The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active ...

Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...

Thousands of U.S. health agency employees were terminated and told it was for poor performance, though they'd received strong ...

Eligible participants were aged 18 or above with no history of SARS-CoV-2 infection receiving either BNT162b2 or CoronaVac vaccine. Exclusion criteria included the presence of clinical signs and ...

Expert Rev Vaccines. 2009;8(3):293-298. A new generation of vaccine antigens with little or no inherent immunostimulatory properties requires potent adjuvants to enhance and direct the vaccine ...

2 vaccination. All individuals received two to three doses of the ancestral mRNA vaccine, followed by either none or one dose of the bivalent vaccine or the XBB.1.5 monovalent vaccine. We used an in ...

In a separate development, the European Medicines Agency (EMA) has accepted GSK’s application for a prefilled syringe presentation of recombinant zoster vaccine, Shingrix, for review ...

Moreover, the increasing R&D investments by leading market players, such as Sanofi, CSL Limited, and GSK plc, for expanding manufacturing capabilities and focus on launching new vaccines will ...

Following a two-week interval, a booster vaccination was administered via the subcutaneous route using 2×10 6 PFU of recombinant HSV-vector vaccines. The subsequent assessment of the immune response ...

Authors constructed a novel HSV-based therapeutic vaccine to cure SIV in a primate model ... the authors that no full mechanistic explanation can be given at this moment. (2) No toxicity data are ...

Public health researchers and doctors said there was no evidence that the vaccine, Gardasil, was linked to the health problems he cited, noting 160 favorable studies on safety. A federal court ...

2,3,4 Over 25 million people in Europe have received GSK’s shingles vaccine since 2018 5 GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted for review the ...